Valuation: InterCure Ltd.

Market Cap 165M 0 145M 133M 124M 235M 15.7B 239M 1.6B 622M 7.75B 621M 608M 26.78B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 302M 0 264M 243M 226M 428M 28.64B 435M 2.92B 1.13B 14.13B 1.13B 1.11B 48.85B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
75.95%
Yield 2024 *
-
Yield 2025 -
1 day+2.78%
1 week-5.56%
Current month-5.56%
1 month+5.60%
3 months+31.40%
6 months-1.27%
Current year-3.92%
1 week 298
Extreme 298
345
1 month 252
Extreme 252
345
Current year 225.3
Extreme 225.3
359
1 year 225.3
Extreme 225.3
605
3 years 225.3
Extreme 225.3
1,346
5 years 225.3
Extreme 225.3
2,635
10 years 146.83
Extreme 146.8255
6,317.95
Manager TitleAgeSince
Chief Executive Officer 55 23/12/2019
Director of Finance/CFO 47 29/02/2020
General Counsel - 31/03/2022
Director TitleAgeSince
Director/Board Member 50 02/09/2015
Director/Board Member 66 13/12/2014
Chairman 55 12/02/2025
Date Insider Type Main position Quantity % Market Cap.
03-17Other

Chief Executive Officer

17,285,455 31.6113%
03-17Other

Director

19,046 0.0348%
03-17Other

Director

15,000 0.0274%
Change 5-day change 1-year change 3-year change Capi.($)
+2.78%-5.56%-38.80%-46.49% 54.5M
0.00%-1.50%+57.60%+219.81% 225M
-1.79%-5.19%-27.89%-35.68% 136M
-2.70%+2.27%+15.38%+100.00% 125M
+3.82%-8.58%+44.50%-0.88% 90.26M
0.00%-15.69%+38.71%-38.57% 87.28M
Average +0.35%-6.13%+14.92%+33.03% 119.73M
Weighted average by Cap. -0.12%-4.66%+22.81%+71.25%

Financials

2024 2025
Net sales 239M 0 209M 193M 179M 339M 22.67B 344M 2.31B 898M 11.19B 897M 877M 38.67B 270M 0 236M 218M 202M 383M 25.64B 390M 2.61B 1.02B 12.66B 1.01B 992M 43.74B
Net income -67.8M -0 -59.33M -54.68M -50.68M -96.2M -6.43B -97.75M -656M -255M -3.18B -255M -249M -10.98B -35.71M -0 -31.25M -28.8M -26.69M -50.67M -3.39B -51.49M -345M -134M -1.67B -134M -131M -5.78B
Net Debt 133M 0 116M 107M 99.24M 188M 12.6B 191M 1.28B 499M 6.22B 498M 488M 21.49B 136M 0 119M 110M 102M 193M 12.94B 197M 1.32B 513M 6.39B 512M 501M 22.07B
Logo InterCure Ltd.
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Employees
285
Date Price Change Volume
08/07/26 ILA 310.90 +2.78% 10,222
07/07/26 ILA 302.50 -3.45% 49,391
06/07/26 ILA 313.30 -3.57% 27,373
03/07/26 ILA 324.90 -0.79% 2,833
02/07/26 ILA 327.50 -3.36% 35,802
  1. Stock Market
  2. Stocks
  3. INCR Stock